T 0754/11 (RNA interference, 3' overhang 19-23 nt dsRNA/MAX-PLANCK-GzFdW, ELMB) of 15.02.2017
- European Case Law Identifier
- ECLI:EP:BA:2017:T075411.20170215
- Date of decision
- 15 February 2017
- Case number
- T 0754/11
- Petition for review of
- -
- Application number
- 01985833.1
- IPC class
- C12Q 1/68
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- RNA INTERFERENCE MEDIATING SMALL RNA MOLECULES
- Applicant name
- Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
Europäisches Laboratorium für Molekularbiologie - Opponent name
- Sirna Therapeutics
Pfizer, Inc.
Roques, Sarah Elizabeth
BASF SE
Silence Therapeutics AG - Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 54European Patent Convention Art 56European Patent Convention Art 83Rules of procedure of the Boards of Appeal Art 13(1)Rules of procedure of the Boards of Appeal Art 13(3)
- Keywords
- Main request - requirements of the EPC met (yes)
- Catchword
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the department of first instance with the order to maintain the patent as amended in the following version:
Description:
Pages 7 - 20 of the patent specification.
Pages 3, 4, 5, 6 and 21 of the amended patent specification received during the oral proceedings before the Board.
Claims:
Claims 1 - 16 of the Main Request filed under cover of a letter dated 13 January 2017.
Drawings:
Figs 1 - 19 of the patent specification.